API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. V /
  3. NRX.V

NurExone Biologic Inc. (NRX V) stock market data APIs

C$0.56 -0.01(-1.8%) as of October 22, 2024
Price chart is built with Anychart

NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.

NurExone Biologic Inc. Financial Data Overview

0.25
0.56
-
0.68
0.25
0.255-1.19
38 025 K
70 417 K
0
-0.02
-0.078
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NRX',
Type: 'Common Stock',
Name: 'NurExone Biologic Inc.',
Exchange: 'V',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

NurExone Biologic Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -4 090 000
  • Earnings Per Share -0.11
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get NurExone Biologic Inc. Earnings via APIs

  • Latest Release 2024-05-29
  • EPS/Forecast -0.02

Get NurExone Biologic Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get NurExone Biologic Inc. latest news via APIs

NurExone Biologic Extends Spinal Cord Injury Therapy Portfolio With New RNA Sequences Promoting Healing and Regeneration

TORONTO and HAIFA, Israel, Nov. 29, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”) has recently unveiled laboratory tests of its...
  • CLINICAL STUDY
  • EXOSOMES
  • EXTRACELLULAR VESICLES
  • NEUROSURGERY
  • NUREXONE BIOLOGIC INC
  • PRODUCT / SERVICES ANNOUNCEMENT
  • REGENERATION OF NEURONS
  • SPINAL CORD INJURY
  • TSX VENTURE EXCHANGE:NRX

NurExone Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”), a pioneering biotechnology company, released...
  • CORPORATE UPDATE
  • EARNINGS RELEASES AND OPERATING RESULTS
  • EXTRACELLULAR VESICLES
  • FDA
  • FINANCIAL REPORT - Q3
  • NUREXONE BIOLOGIC INC
  • SPINAL CORD INJURY
  • TSX VENTURE EXCHANGE:NRX
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com